Evra Transdermal Patches 3S

Evra Transdermal Patch Contains Norelgestromin (150 Mcg) And Ethinylestradiol (20 Mcg) As Its Active Ingredients. This Combination Is A Hormonal Contraceptive That Works By Preventing Ovulation, Thickening Cervical Mucus, And Altering The Uterine Lining To Prevent Fertilization. Evra Transdermal Patch Is A Convenient, Easy-To-Use Contraceptive Option Designed For Women Seeking A Non-Oral Birth Control Method. The Patch Is Worn On The Skin And Delivers A Continuous Dose Of Hormones Through Transdermal Absorption. Side Effects Common Side Effects Of Evra Transdermal Patch May Include: Nausea Or Vomiting Headache Or Migraine Breast Tenderness Weight Changes Skin Irritation At The Application Site Rare But Serious Side Effects May Include: Increased Risk Of Blood Clots Severe Allergic Reactions (Swelling Of Lips, Throat, Or Face) Stroke Or Heart Attack, Especially In Smokers Or Those With Predisposing Risk Factors Liver Dysfunction Patients Should Consult A Healthcare Provider If Any Severe Or Persistent Side Effects Occur. Precautions Before Using Evra Transdermal Patch, Consider The Following Precautions: Not Suitable For Women Over 35 Years Old Who Smoke. Avoid Use In Patients With A History Of Blood Clots, Heart Disease, Or Stroke. Discontinue Use If Any Symptoms Of Blood Clots (Leg Swelling, Chest Pain, Sudden Shortness Of Breath) Occur. Inform Your Healthcare Provider About Any History Of Liver Disease, Breast Cancer, Or Other Hormonal Conditions. May Interact With Other Medications Like Antibiotics, Antifungals, Or Anticonvulsants. Always Consult A Healthcare Provider Before Starting This Method Of Contraception.